Research suggests that cuproptosis is involved in promoting inflammatory osteolysis, with some studies indicating that altered copper metabolism plays a crucial role in this process. Copper metabolism has been identified as a potential therapeutic target for inflammatory osteolysis. The specific mechanism is thought to involve GYS1-mediated glycogen metabolism, although the details of this relationship are still being explored.